Pages that link to "Q31032847"

The following pages link to STAT3 Knockdown Reduces Pancreatic Cancer Cell Invasiveness and Matrix Metalloproteinase-7 Expression in Nude Mice (Q31032847):

Displaying 27 items.

• Exocrine pancreatic carcinogenesis and autotaxin expression (Q28482954) (← links)
• The cation channel Trpv2 is a new suppressor of arthritis severity, joint damage, and synovial fibroblast invasion (Q28573570) (← links)
• Role of STAT3 in cancer metastasis and translational advances (Q31142794) (← links)
• OSU-A9 inhibits pancreatic cancer cell lines by modulating p38-JAK-STAT3 signaling (Q33710074) (← links)
• MicroRNA-1299 is a negative regulator of STAT3 in colon cancer (Q33721111) (← links)
• STAT3 down regulates LC3 to inhibit autophagy and pancreatic cancer cell growth (Q33757027) (← links)
• MiR-130b is a prognostic marker and inhibits cell proliferation and invasion in pancreatic cancer through targeting STAT3 (Q34989346) (← links)
• Metformin can block precancerous progression to invasive tumors of bladder through inhibiting STAT3-mediated signaling pathways (Q36005565) (← links)
• Elevated GRP78 expression is associated with poor prognosis in patients with pancreatic cancer (Q36245668) (← links)
• Applying Small Molecule Signal Transducer and Activator of Transcription-3 (STAT3) Protein Inhibitors as Pancreatic Cancer Therapeutics (Q36918125) (← links)
• Expressions of Matrix Metalloproteinases 2, 7, and 9 in Carcinogenesis of Pancreatic Ductal Adenocarcinoma (Q37080740) (← links)
• STAT3 modulates cigarette smoke-induced inflammation and protease expression (Q37208237) (← links)
• Risk factors and therapeutic targets in pancreatic cancer (Q37317310) (← links)
• Randomized, Double-Blind, Phase II Study of Ruxolitinib or Placebo in Combination With Capecitabine in Patients With Metastatic Pancreatic Cancer for Whom Therapy With Gemcitabine Has Failed. (Q37384293) (← links)
• Challenges and advances in mouse modeling for human pancreatic tumorigenesis and metastasis (Q37411831) (← links)
• Clinicopathological significance of SMAD4 loss in pancreatic ductal adenocarcinomas: a systematic review and meta-analysis (Q37725506) (← links)
• STAT transcription factors in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention (Q38116768) (← links)
• The role of inflammation in pancreatic cancer (Q38211076) (← links)
• STAT3 in Cancer-Friend or Foe? (Q38226313) (← links)
• SMAD4 and its role in pancreatic cancer (Q38281261) (← links)
• Upregulation of miR-129-5p affects laryngeal cancer cell proliferation, invasiveness, and migration by affecting STAT3 expression (Q38839833) (← links)
• STAT3 targeting by polyphenols: Novel therapeutic strategy for melanoma. (Q39023307) (← links)
• Shifting paradigm of developing biologics for the treatment of pancreatic adenocarcinoma (Q39453577) (← links)
• Activation of the IL-6R/Jak/stat pathway is associated with a poor outcome in resected pancreatic ductal adenocarcinoma. (Q54447837) (← links)
• High expression of interleukin-22 and its receptor predicts poor prognosis in pancreatic ductal adenocarcinoma. (Q54744700) (← links)
• STAT3 promotes chronic lymphocytic leukemia progression through upregulating SMYD3 expression (Q90401892) (← links)
• Mitochondria-Targeted Honokiol Confers a Striking Inhibitory Effect on Lung Cancer via Inhibiting Complex I Activity (Q93074180) (← links)